For many women living with lipedema, the journey to a diagnosis is often filled with confusion, frustration, and unanswered questions. Symptoms may include pain, heaviness, tenderness, easy bruising, swelling, and changes in body shape that do not respond to diet and exercise. Yet these signs are often misunderstood or dismissed, leaving many patients searching for answers for years before receiving an accurate diagnosis.
Lipedema Awareness Month is dedicated to changing that. Observed each June, Lipedema Awareness Month serves as an opportunity to increase understanding of this chronic condition, encourage earlier recognition, and help more patients access the specialized care and support they deserve. It is also a time to amplify the voices of those living with lipedema, promote greater understanding of the condition, and foster meaningful conversations about diagnosis, treatment, and long-term care.
At Advanced Lipedema Treatment (ALT) at The Roxbury Institute, awareness is only the beginning. Through research, education, diagnosis, conservative treatment, and specialized surgical care, our team is committed to advancing the understanding of lipedema while helping patients navigate every stage of their journey with confidence and support. As we recognize Lipedema Awareness Month, we remain focused on expanding access to care, advancing research, and helping more patients find the answers they have often spent years searching for.
Despite affecting millions of women worldwide, lipedema remains one of the most misunderstood and underrecognized chronic conditions. Increased awareness plays an important role in helping patients recognize potential symptoms earlier, encouraging healthcare professionals to become more familiar with the condition, and improving access to specialized care.
Awareness also helps drive progress beyond diagnosis. Greater visibility can support research initiatives, encourage conversations about treatment options, and connect patients with educational resources, support networks, and healthcare providers who understand the complexities of the condition. As understanding of lipedema continues to grow, so does the opportunity to improve the patient experience and expand access to care.
While significant progress has been made in recent years, there is still important work to be done. Many patients continue to face delays in diagnosis, limited awareness among healthcare providers, and barriers to treatment. Lipedema Awareness Month serves as a reminder of how far the lipedema community has come—and how much progress can still be achieved through continued education, advocacy, research, and collaboration.
While lipedema remains underdiagnosed, awareness and understanding of the condition have advanced significantly in recent years. What was once a condition that received limited attention within the broader medical community has become the focus of growing research efforts, educational initiatives, patient advocacy campaigns, and clinical advancements around the world.
One of the most significant developments has been the expansion of lipedema research. Researchers continue to investigate the biological and genetic mechanisms that contribute to the condition, including differences in adipose tissue, inflammation, fibrosis, connective tissue abnormalities, and gene expression. These efforts are helping advance our understanding of why lipedema develops, how it progresses, and how future diagnostic tools may be improved.
Awareness efforts have also helped drive greater collaboration among researchers, healthcare providers, patient advocates, and organizations dedicated to advancing lipedema care. As a result, more educational resources, clinical guidelines, research initiatives, and professional discussions are available today than ever before, helping both patients and providers better understand the condition and its management.
Treatment options have evolved alongside research advancements.Today, patients have access to a wider range of conservative therapies designed to help manage symptoms, support quality of life, and complement care both before and after surgical treatment. Compression therapy, manual lymphatic drainage (MLD), pneumatic compression devices, exercise programs, nutritional support, and anti-inflammatory lifestyle strategies are increasingly being incorporated into comprehensive treatment plans based on individual patient needs.
Lipedema specialists have also continued to refine specialized surgical techniques designed to remove diseased adipose tissue while preserving surrounding lymphatic structures. These advancements have expanded treatment possibilities for many patients when conservative management alone is not sufficient.
Awareness efforts have also helped increase recognition of lipedema among healthcare professionals, insurers, researchers, and the general public. The inclusion of lipedema in the ICD-11 classification system represents another important step toward improving recognition, supporting more accurate diagnosis, and encouraging broader understanding of the condition on a global scale.
Researchers are also continuing to explore emerging areas of treatment and management, including the potential role of GLP-1 receptor agonists and other therapies that may help address some of the metabolic and inflammatory components associated with lipedema. While additional research is needed, these ongoing investigations reflect the growing commitment to improving care and expanding treatment options for patients.
While there is still much to learn, each of these advancements represents meaningful progress. Together, they are helping create a future where more patients receive timely diagnoses, have access to specialized care, and benefit from a growing body of research dedicated to improving outcomes.
As awareness of lipedema continues to grow, so does the need for specialized programs dedicated to research, diagnosis, treatment, education, and long-term patient support. The Advanced Lipedema Treatment Program at The Roxbury Institute is committed to advancing the understanding of lipedema while helping patients access comprehensive care at every stage of their journey.
Founded by Dr. David Amron, The Advanced Lipedema Treatment Program at The Roxbury Institute has spent more than two decades focused exclusively on the diagnosis and treatment of lipedema. Throughout that time, the program has contributed to the evolution of lipedema care through patient education, research initiatives, specialized surgical techniques, conservative treatment strategies, and ongoing advocacy efforts designed to improve recognition of the condition.
As awareness of lipedema continues to grow, access to specialized diagnosis, treatment, and long-term support remains an important priority. The Advanced Lipedema Treatment Program at The Roxbury Institute has continued to expand its reach through new programs, locations, and initiatives designed to help more patients access expert care.
Led by Dr. Karen Herbst, the Diagnostic and Preventative Center in Tucson, Arizona, was established to address a critical gap in lipedema care: access to comprehensive diagnosis, prevention, and long-term management. Through advanced diagnostic assessments, metabolic and hormonal evaluations, imaging studies, and individualized treatment planning, the center helps patients gain a deeper understanding of their condition while identifying strategies to support overall health and symptom management.
By expanding services beyond surgical treatment alone, the Diagnostic and Preventative Center provides patients with access to specialized resources, education, and preventative care designed to support them throughout every stage of their journey.
The Advanced Lipedema Treatment Program at The Roxbury Institute has also expanded access to care through its Utah location, led by Dr. David Smart. This expansion has increased access to specialized lipedema expertise for patients throughout Utah and surrounding states, helping more individuals connect with experienced providers closer to home.
As demand for specialized lipedema care continues to grow, expanding into additional regions helps reduce barriers to access while ensuring that more patients have the opportunity to receive comprehensive evaluation, treatment, and long-term support from providers who understand the complexities of the condition.
Research remains a cornerstone of The Advanced Lipedema Treatment Program at The Roxbury Institute. Through ongoing collaborations, educational initiatives, and support for scientific advancement, the team continues to contribute to a growing body of knowledge surrounding lipedema.
Founded by Dr. David Amron, The Lipedema Society was established to help advance research, education, clinical standards, and collaboration within the lipedema community. Through its work, the organization aims to bridge the gap between research and clinical practice while supporting continued progress in the diagnosis, treatment, and understanding of lipedema.
By bringing together healthcare professionals, researchers, patient advocates, and industry leaders, The Lipedema Society helps foster meaningful collaboration while working to improve standards of care for patients worldwide.
Education remains one of the most powerful tools in improving awareness and recognition of lipedema. Through physician-led webinars, patient resources, educational video content, and the Lippy Logic™ Educational Series, The Advanced Lipedema Treatment Program at The Roxbury Institute continues to provide accessible, evidence-based information to patients, caregivers, and healthcare professionals.
These educational initiatives help patients better understand their condition, navigate treatment options, and make informed decisions about their care while also helping increase awareness among medical professionals.
While surgical treatment plays an important role for most patients, comprehensive lipedema care extends beyond the operating room. The Advanced Lipedema Treatment Program at The Roxbury Institute emphasizes a multidisciplinary approach that recognizes the metabolic, lymphatic, vascular, physical, and emotional factors that may accompany the condition.
Patients have access to guidance on conservative treatment strategies, including compression therapy, manual lymphatic drainage, nutritional support, exercise recommendations, and symptom management approaches that can be incorporated into their long-term care plans.
The Roxbury Institute has also expanded its commitment to patient wellness through the development of The Roxbury Institute Supplement Program. Created by physicians, the program was designed to support metabolic health, inflammation support, and lymphatic wellness while complementing the institute's broader focus on comprehensive patient care.
Education and treatment are only part of the journey. The Advanced Lipedema Treatment Program at The Roxbury Institute also recognizes the importance of community and peer support.
The Advanced Lipedema Treatment Program at The Roxbury Institute recognizes that education and support extend beyond the clinical setting. Through our private Facebook community, which has grown to nearly 3,000 members as of this month, patients have the opportunity to connect with others who share similar experiences and goals.
Exclusive to our patients and those exploring care through The Advanced Lipedema Treatment Program at The Roxbury Institute, the group serves as a trusted space to ask questions, share experiences, discuss recovery, exchange practical tips, and learn from others navigating different stages of their lipedema journey. Members regularly engage in conversations about diagnosis, treatment planning, compression, recovery, lifestyle considerations, and long-term management.
By creating a space for connection, encouragement, and shared experiences, our community helps ensure that patients have access not only to specialized medical expertise, but also to a supportive network of individuals who understand the realities of living with lipedema.
If you are a patient of The Advanced Lipedema Treatment Program at The Roxbury Institute, we invite you to join our private Facebook community: https://www.facebook.com/share/g/18diLXqmW4/
Improving access to care remains a major priority for The Advanced Lipedema Treatment Program at The Roxbury Institute.
Dr. David Amron, Dr. Aria Vazirnia, and Dr. David Smart are in-network with Aetna for eligible lipedema procedures, helping qualified patients access specialized care through their insurance benefits. With providers available at both our Los Angeles and Utah locations, patients have additional options when seeking specialized lipedema treatment. Coverage is subject to benefits verification, medical necessity determination, and prior authorization requirements.
To further support patients through what can often be a complex insurance process, The Advanced Lipedema Treatment Program at The Roxbury Institute maintains a dedicated in-house insurance team. This team assists patients with benefits verification, insurance education, prior authorization requirements, and navigating the approval process, helping patients better understand their coverage options and available pathways to treatment.
While there is still much to learn about lipedema, The Advanced Lipedema Treatment Program at The Roxbury Institute remains committed to advancing research, expanding access to specialized care, improving education, and supporting patients through every stage of their journey. Through continued innovation, collaboration, and advocacy, the program is helping shape a future where lipedema is better understood, more widely recognized, and more effectively treated than ever before.
If you would like to learn more about lipedema, explore your treatment options, or schedule a consultation, contact The Advanced Lipedema Treatment Program at The Roxbury Institute. Our team is here to help answer your questions and guide you toward the resources and care that best fit your needs.
